The Clinical Potential and Therapeutic Differentiation of MediciNova's MN-166 Featured in Neurology Articles
April 01, 2010 06:00 ET
|
MediciNova, Inc.
SAN DIEGO, April 1, 2010 (GLOBE NEWSWIRE) -- MediciNova, Inc, a biopharmaceutical company publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka Securities...
MediciNova Reports Fourth Quarter and Full Year 2009 Results
March 24, 2010 17:10 ET
|
MediciNova, Inc.
SAN DIEGO, March 24, 2010 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
MediciNova Reports Positive Preliminary Results From a Phase Ib Clinical Trial of MN-221 in Moderate to Severe COPD Patients
March 17, 2010 16:30 ET
|
MediciNova, Inc.
SAN DIEGO, March 17, 2010 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
MediciNova Appoints Dr. Kirk Johnson Chief Scientific Officer
February 01, 2010 06:00 ET
|
MediciNova, Inc.
SAN DIEGO, Feb. 1, 2010 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
MediciNova Extends Conversion Deadline to January 11, 2010
January 05, 2010 06:00 ET
|
MediciNova, Inc.
SAN DIEGO, Jan. 5, 2010 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
MediciNova Completes Acquisition of Avigen
December 18, 2009 21:00 ET
|
MediciNova, Inc.
SAN DIEGO, Dec. 18, 2009 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
MediciNova and Avigen Stockholders Approve Merger
December 17, 2009 19:40 ET
|
MediciNova, Inc.
SAN DIEGO and ALAMEDA, Calif., Dec. 17, 2009 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market...
MediciNova and Avigen Confirm Stockholder Election Deadline
December 15, 2009 06:00 ET
|
MediciNova, Inc.
SAN DIEGO and ALAMEDA, Calif., Dec. 15, 2009 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market...
MediciNova and Avigen Announce Stockholder Election Deadline and Update to Estimated Merger Consideration
December 09, 2009 17:00 ET
|
MediciNova, Inc.
SAN DIEGO and ALAMEDA, Calif., Dec. 9, 2009 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market...
MediciNova Reports Third Quarter 2009 Results
November 12, 2009 17:10 ET
|
MediciNova, Inc.
SAN DIEGO, Calif., Nov. 12, 2009 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the...